Webcast: Targeting COPD with type 2 inflammation - emerging biologic landscape
Explore the Latest Insights in COPD Management and Biologic Therapies.
Watch this engaging and educational session tailored for pulmonologists looking to deepen the understanding of Chronic Obstructive Pulmonary Disease (COPD) and the latest advancements in biologic therapies.
Meet Our Expert Panel
- Prof. Dr. Frits Franssen
Pulmonologist, Maastricht UMC+, the Netherlands
- Dr. Asger Sverrild
Pulmonologist, Bispebjerg Hospital, Denmark
- Prof. Dr. Wim Janssens
Pulmonologist, UZ Leuven, Belgium
- Prof. Dr. Janwillem Kocks
General Practitioner, GPRI & UMCG, the Netherlands
Watch the Full Webinar
Don’t miss the opportunity to access the complete webcast Targeting COPD with type 2 inflammation - emerging biologic landscape.
Webcast segments
You can also watch specific parts of the webcast in the separate videos provided below.
Introduction to the webcast: Targeting COPD with type 2 inflammation - emerging biologic landscape
Presented by Prof. Dr. Janwillem Kocks, this session provides an overview of COPD, its prevalence, and its impact on patient health.
Evolving Clinical Landscape in COPD and Implications for Disease Management
Gain insights into the latest advancements in COPD treatments and their effect on disease management strategies, presented by Prof. Dr. Wim Janssens.
Heterogeneity of Inflammation Pathways in COPD
Understand the diverse inflammation pathways in COPD and their implications for personalized care, presented by Dr. Asger Sverrild.
Clinical Presentation of COPD Through Disease Pathology
Explore the clinical features and underlying mechanisms of COPD with this video presented by Prof. Dr. Frits Franssen.
För att läsa den här sidan måste du logga in eller registrera dig.
Disclaimer and references
The webcast is produced by Springer Healthcare and sponsored by Sanofi.
All references are cited within the video, and the disclosures and SmPC are also included in the webcast content.
Relaterade Artiklar
COPD Research Forum
In this COPD Research Forum, leading healthcare professionals discuss critical topics such as IL-33, lung function trajectories, and mucus plugging in COPD.
SE-FILMEN-HÄR
